Notice of Privacy Incident
Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D&T) Committee Meeting Results for: March 16, 2016

Drugs and Therapeutics (D & T) Committee Meeting Results March 16, 2016
Drug Name	Review Type	Committee Recommendation	Prior Approval Status – Final Determination
Prezcobix	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Envarsus XR	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Nucala	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Zepatier	New Drug Initial Review	Preferred with Prior Approval Required	Preferred with Prior Approval Required
Zomacton	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Veltassa	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Kitabis PAK	New Drug Appeal	Require Prior Approval	Prior Approval Required
Jadenu	New Drug Appeal	Require Prior Approval	Prior Approval Required
Triumeq	New Drug Appeal	Require Prior Approval	Prior Approval Required
Invega Trinza	New Drug Appeal	Require Prior Approval	Prior Approval Required

Drugs and Therapeutics (D & T) Committee